scorecardresearch
Friday, July 25, 2025
TopicGlaxoSmithKline

Topic: GlaxoSmithKline

Blob that created history — tracking six-decade quest for respiratory syncytial virus vaccine

GlaxoSmithKline’s vaccine for respiratory syncytial virus was approved by The Medicines and Healthcare products Regulatory Agency in Britain on Monday.

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

GlaxoSmithKline, CureVac team up to develop vaccines to tackle Covid variants

The immunisations may be used to protect people who haven’t been inoculated or as booster shots if immunity from other vaccines wanes.

Sanofi and Glaxo start human trials for Covid-19 vaccine

The drugmakers, who have 11 trial sites across the US, aim to have results by December, allowing for the final phase of trials to begin.

Sanofi expects to get approval for its coronavirus vaccine in first half of 2021

Paris-based pharma giant Sanofi’s program with Britain's Glaxo is one of dozens sprinting to deliver a vaccine to help end the pandemic.

Unilever needs luck to gain energy from Horlicks deal in India

Horlicks is facing a challenge, even in India. The drink is losing its star status as the ‘healthy’ morning and after-school drink.

Glaxo to consider selling its stake in Indian consumer unit worth $3.1 bn

Revenue at GlaxoSmithKline's consumer unit in India has decreased in the last two years.  Its bestselling malted milk drink brand Horlicks will also be sold.

On Camera

Thailand-Cambodia clash is more than a border fight—it’s a new front in Cold War 2.0

The Southeast Asian theatre is central to the Great Power contest between the US and China. It’s also a landscape where middle powers—France, the UK, Turkey—are shaping the strategic environment.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

DRDO successfully tests latest version of UAV-launched precision missile, ULPGM-V3

Capable of being fired in plain and high-altitude areas, it has day-and-night capability and two-way data link to support post-launch target, aim-point update.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.